Topiramate in clinical practice: First year's postlicensing experience in a specialist epilepsy clinic

Journal of Neurology Neurosurgery and Psychiatry

Volumn 66, Issue 6, 1999, Pages 759-763

  Kellett, Mark W ^a   Smith, David F ^a   Stockton, Paul A ^a   Chadwick, David W ^a  

^a WALTON CENTRE FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

Author keywords

Epilepsy; Topiramate

Indexed keywords

ANTICONVULSIVE AGENT; TOPIRAMATE;

ADULT; ARTICLE; BEHAVIOR DISORDER; COGNITIVE DEFECT; DEPRESSION; DISEASE CLASSIFICATION; DROWSINESS; DRUG EFFICACY; EPILEPSY; FEMALE; FOCAL EPILEPSY; HUMAN; LEARNING DISORDER; MAJOR CLINICAL STUDY; MALE; MYOCLONUS EPILEPSY; PRIORITY JOURNAL; PSYCHOSIS; RETROSPECTIVE STUDY;

EID: 0032988346     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.66.6.759     Document Type: Article

References (14)

1. Marson AG, Kadir ZA, Chadwick DW. New antiepileptic drugs: a systematic review of their efficacy and tolerability. BMJ 1996;313:1169-74.
2. Chadwick DW. An overview of the efficacy and tolerability of new antiepileptic drugs. Epilepsia 1997;38(suppl 1):S59-62.
3. Mignot G. Drug trials in epilepsy. BMJ 1996;313:1158.
4. Walker MC, Li LM, Sander JW. Long-term use of lamotrigine and vigabatrin in severe refractory epilepsy: audit of outcome. BMJ 1996;313:1184-5.
5. Wong IC. New antiepileptic drugs. Study suggests that under a quarter of patients will still be taking the new drugs after six years. BMJ 1997;314:603-1.
6. Schapel G, Chadwick D. A survey comparing lamotrigine and vigabatrin in everyday clinical practice. Seizure 1996;5: 267-70.
7. Abacus Concepts. Using statview. Berkeley, CA: Abacus concepts, 1996.
8. Sander JWAS. Use of topiramate in the broad spectrum of patients in clinical practice. Proceedings from satellite symposium supported by Janssen Cilag. "Topiramate an expanding spectrum of clinical use" at the 22nd International Epilepsy Congress. Dublin: Janssen Cilag, 1997.
9. Reife RA, Pledger GW. Topiramate as adjunctive therapy in refractory partial epilepsy: pooled analysis of data from five double-blind, placebo-controlled trials. Epilepsia 1997; 38(suppl 1):S31-3.
10. Rosenfeld WE, Sachdeo RC, Faught RE, et al. Long-term experience with topiramate as adjunctive therapy and as monotherapy in patients with partial onset seizures: retrospective survey of open-label treatment. Epilepsia 1997;38(suppl 1):S34-6.
11. Biton V. Preliminary open-label experience with topiramate in primary generalized seizures. Epilepsia 1997;38(suppl 1):S42-1.
12. Shorvon SD. Safety of topiramate: adverse events and relationships to dosing. Epilepsia 1996;37(suppl 2):S18-22.
13. Sander JW. Practical aspects of the use of topiramate in patients with epilepsy. Epilepsia 1997;38(suppl 1):S56-8.
14. Betts T, Smith K, Khan G. Severe psychiatric reactions to topiramate. Epilepsia 1997;38(suppl 3):64.